Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers
Condition: Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Interventions: Drug: HMBD-001; Drug: Docetaxel; Drug: Cetuximab Sponsors: Hummingbird Bioscience; Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Erbitux | Germany Health | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study | Taxotere